4-((R)-2-Hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino)butyl 2-((3-((S)-Phenyl(((R)-quinuclidin-3-yloxy)carbonylamino)methyl)phenoxy)methyl)oxazole-4-carboxylate

ID: ALA5208957

Chembl Id: CHEMBL5208957

PubChem CID: 168296356

Max Phase: Preclinical

Molecular Formula: C41H45N5O9

Molecular Weight: 751.84

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H](c1ccccc1)c1cccc(OCc2nc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)co2)c1)O[C@H]1CN2CCC1CC2

Standard InChI:  InChI=1S/C41H45N5O9/c47-33-13-11-30(31-12-14-36(49)44-39(31)33)34(48)22-42-17-4-5-20-52-40(50)32-24-54-37(43-32)25-53-29-10-6-9-28(21-29)38(27-7-2-1-3-8-27)45-41(51)55-35-23-46-18-15-26(35)16-19-46/h1-3,6-14,21,24,26,34-35,38,42,47-48H,4-5,15-20,22-23,25H2,(H,44,49)(H,45,51)/t34-,35-,38-/m0/s1

Standard InChI Key:  UTMUSTVNAHXQQF-XFKJAIHHSA-N

Alternative Forms

  1. Parent:

    ALA5208957

    ---

Associated Targets(Human)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trachea (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GPM3 Muscarinic acetylcholine receptor M3 (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adrb2 Beta-2 adrenergic receptor (1382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 751.84Molecular Weight (Monoisotopic): 751.3217AlogP: 4.97#Rotatable Bonds: 16
Polar Surface Area: 188.48Molecular Species: BASEHBA: 12HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.39CX Basic pKa: 9.81CX LogP: 2.83CX LogD: 0.55
Aromatic Rings: 5Heavy Atoms: 55QED Weighted: 0.07Np Likeness Score: -0.31

References

1. Carzaniga L, Linney ID, Rizzi A, Delcanale M, Schmidt W, Knight CK, Pastore F, Miglietta D, Carnini C, Cesari N, Riccardi B, Mileo V, Venturi L, Moretti E, Blackaby WP, Patacchini R, Accetta A, Biagetti M, Bassani F, Tondelli M, Murgo A, Battipaglia L, Villetti G, Puccini P, Catinella S, Civelli M, Rancati F..  (2022)  Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.,  65  (15.0): [PMID:35901125] [10.1021/acs.jmedchem.2c00609]

Source